Share
High drug prices have been a focus of Congress and the Trump Administration for the past year, with insulin becoming the prime example of the negative impact increasing drug prices are having on patients. The Endocrine Society has made addressing the high cost of insulin a priority for the past three years. We have urged...
Share
A novel way to reach even more patients, clinicians, and researchers is to take your endocrinology skill into the business world. Here we highlight an ENDO 2020 session that will show attendees how industry could be a viable route for researchers and physicians alike. Last year, at ENDO 2019 in New Orleans, three entrepreneurs at...
Share
The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session. Several states are considering legislation that would carry penalties of jail time and fines for healthcare providers who treat transgender teenagers using evidence-based practices. These...
Share
After months of bargaining and numerous stalemates, the House of Representatives and Senate reached agreement on Fiscal Year 2020 appropriations just before funding expired on December 20. The deal also provided a “Christmas Tree” legislative vehicle for various policy measures. The spending deal was divided into two packages of individual bills covering funding for every...
